Barbigerone Inhibits Tumor Angiogenesis, Growth and Metastasis in Melanoma |
Yang, Jian-Hong
(Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Hu, Jia (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Wan, Li (State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicine, Chengdu University of Traditional Chinese Medicine) Chen, Li-Juan (Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) |
1 | Zhao CJ, Yang HS, Shi HS, et al (2011). Distinct Contributions of Angiogenesis and Vascular Co-option during the Initiation of Microtumors and Micrometastases. Carcinogenesis, 32, 1143-50. DOI |
2 | Ye HY, Zhong SJ, Li YF, et al (2010). Enrichment and isolation of barbigerone from Millettia pachycarpa Benth. using highspeed counter-current chromatography and preparative HPLC. J Sep Sci, 33, 1010-7. |
3 | Yenesew A, Derese S, Midiwo JO, Oketch-Rabah HA, Lisgarten J, Palmer R, et al (2003). Anti-plasmodial activities and X-ray crystal structures of rotenoids from Millettia usaramensis subspecies usaramensis". Phytochem, 64, 773-9. DOI |
4 | Yenesew A, Midiwo JO, Waterman PG (1998). Rotenoids, isoflavones and chalcones from the stem bark of Millettia usaramensis subspecies usaramensis. Phytochem, 47, 295-300. DOI |
5 | Zhang D, Li B, Shi J, et al (2010). Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF).-A and VEGF-C with a Receptor-Immunoglobulin Fusion Protein. Cancer Res, 70, 2495-503. DOI |
6 | Tozer GM, Kanthou C, Baguley BC (2005). Disrupting tumor blood vessels. Nat Rev Cancer, 5, 423-35. DOI |
7 | Reddy KB, Nabha SM, Atanaskova N (2003). Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev, 22, 395-403. DOI ScienceOn |
8 | Small JV, Rottner K, Kaverina I, Anderson KI (1998). Assembling an actin cytoskeleton for cell attachment and movement. Biochim Biophys Acta, 1404, 271-81. DOI |
9 | Tournaire R, Simon MP, le Noble F, et al (2004). A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep, 5, 262-7. DOI ScienceOn |
10 | Uzgare AR, Kaplan PJ, Greenberg NM (2003). Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate, 55, 128-39. DOI |
11 | Vicent S, Garayoa M, Lopez-Picazo JM, et al (2004). Mitogenactivated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin Cancer Res, 10, 3639-49. DOI ScienceOn |
12 | Vilain C (1980). Barbigerone, a new pyranoisoflavone from seeds of Tephrosia barbigera. Phytochem, 19, 988-9. DOI |
13 | Wangensteen H, Miron A, Alamgir M, et al (2006). Antioxidant and 15-lipoxygenase inhibitory activity of rotenoids, isoflavones and phenolic glycosides from Sarcolobus globosus. Fitoterapia, 77, 290-5. DOI ScienceOn |
14 | Gupta GP, Massague J (2006). Cancer metastasis: building a framework. Cell, 127, 679-95. DOI ScienceOn |
15 | Webb CP, Van Aelst L, Wigler MH, Woude GF (1998). Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci USA, 95, 8773-8. DOI |
16 | Hsia DA, Mitra SK, Hauck CR, et al (2003). Differential regulation of cell motility and invasion by FAK. J Cell Biol, 160, 753-67. DOI ScienceOn |
17 | Folkman J, Shing Y (1992). Angiogenesis. J Biol Chem, 267, 10931-4. |
18 | Johnson GL, Lapadat R (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298, 1911-2. DOI ScienceOn |
19 | Huang D, Ding Y, Luo WM, et al (2008). Inhibition of MAPK Kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res, 68, 81-8. DOI ScienceOn |
20 | Kruger EA, Duray PH, Price DK, Pluda JM, Figg WD (2001). Approaches to preclinical screening of antiangiogenic agents. Semin Oncol, 28, 570-6. DOI |
21 | Lee JC, Laydon JT, Mcdonnell PC, et al (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-46. DOI ScienceOn |
22 | Li X, Wang X, Ye H, Peng A, Chen L (2012). Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-smallcell lung cancer xenografts growth through VEGFR2 signaling pathways.Cancer Chemother Pharmacol, 70, 425-37. DOI |
23 | Olson MF, Sahai E (2009). The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis, 26, 273-87. DOI ScienceOn |
24 | Patan S (2004). Vasculogenesis and angiogenesis. Cancer Treat Res, 117, 3-32. DOI |
25 | Carmeliet P, Base M (2008). Metabolism and therapeutic angiogenesis. N Engl J Med, 358, 2511-2. DOI |
26 | Raingeaud J, Gupta S, Rogers JS, et al (1995). Pro-inflammatory cytokines and environmental stress cause p38 mitogenactivated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem, 31, 270, 7420-6. DOI ScienceOn |
27 | Amundadottir LT, Leder P (1998). Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene, 16, 737-46. DOI |
28 | Carmeliet P (2003). Angiogenesis in health and disease. Nat Med, 9, 653-60. DOI ScienceOn |
29 | Carmeliet P, Jain RK (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249-57. DOI ScienceOn |
30 | Davidson B, Konstantinovsky S, Kleinberg L, et al (2006). The mitogen-activated protein kinases (MAPK). p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol, 102, 453-61. DOI |
31 | Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN (2006). Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci, 27, 297-309. DOI |
32 | Ferrara N, Kerbel RS (2005). Angiogenesis as a therapeutic target. Nature, 438, 967-74. DOI ScienceOn |
33 | Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-6. DOI ScienceOn |
34 | Wangensteen H, Alamgir M, Rajia S, Samuelsen AB, Malterud KE (2005). Rotenoids and isoflavones from Sarcolobus globosus. Planta Med, 71, 754-8. DOI |